同位体 2 つの安定を用いる液体クロマトグラフィー質量によってスフィンゴミエリンの定量的および定性的な方法ラベル スフィンゴミエリン種

Executive Industry Relevance

This method enables precise structural and quantitative analysis of sphingomyelin species in biological samples, supporting lipid biomarker discovery and mechanistic de-risking in early drug development. By characterizing sphingomyelin composition, it enhances target validation in pathways involving membrane lipid dynamics and signaling. The approach provides predictive confidence for lipid-modulating therapeutics and supports portfolio triage through quantitative lipid profiling.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables interrogation of sphingolipid metabolism pathways to clarify therapeutic hypotheses in lipid-related diseases.
• Operational Value: Provides qualitative structural data via MS3 to identify sphingoid long-chain base and N-acyl moiety composition for target de-risking.

Screening & Assay Development

• Scientific Value: Delivers quantitative sphingomyelin measurements using stable isotope-labeled internal standards for assay standardization.
• Operational Value: Supports reproducible lipid extraction and LC-MS/MS workflows suitable for high-throughput screening platforms.

Translational & Preclinical Research

• Scientific Value: Facilitates disease-relevant sphingolipid profiling in preclinical models to align with translational biomarker strategies.
• Operational Value: Ensures continuity from discovery to preclinical validation through consistent lipid quantification across sample types.

Pipeline & Workflow Integration

The method integrates into early discovery workflows by providing structural lipid data that informs target selection and pathway analysis prior to lead identification.

• Discovery Biology: Supports hypothesis testing and pathway clarification by quantifying sphingomyelin species involved in cellular signaling and membrane dynamics.
• Screening: Enables assay readiness through standardized lipid extraction and MRM-based detection for compound effect evaluation.
• Analytics: Generates quantitative peak area data and qualitative MS3 spectra to compare lipid modulation across experimental conditions.
• Translational Research: Connects to preclinical continuity by enabling sphingomyelin profiling in disease models for biomarker alignment.
• Enterprise Reuse: Establishes a reusable lipid analysis platform applicable across therapeutic areas involving membrane biology.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence in lipid target validation through precise structural and quantitative sphingomyelin data.
• Operational Value: Enhances reproducibility and scalability via isotope-labeled internal standards and standardized extraction protocols.
• Strategic Value: Improves go/no-go decisions by reducing mechanistic ambiguity in lipid pathway modulation.
• Portfolio Impact: Enables risk-adjusted prioritization of lipid-targeting compounds based on quantitative sphingomyelin response data.

Implementation Considerations

• Requires expertise in lipid extraction, LC-MS/MS operation, and MS3 data interpretation for structural elucidation.
• Dependent on access to triple quadrupole or linear ion trap mass spectrometry systems capable of MS3 acquisition.
• Necessitates cross-team standardization of lipid extraction and derivatization protocols for reproducible results.
• Involves adaptation considerations when applying the method to diverse biological matrices beyond cultured cells.
• Limited by the availability of sphingomyelin isotope standards for accurate quantification across diverse lipid species.

Biopharma FAQs